Metaraminol
Back to searchMolecule Structure
Scientific Name
Metaraminol
Description of the Drug
Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00610
http://www.drugbank.ca/drugs/DB00610
Brand Name(s)
Not Available
Company Owner(s)
Fresenius Kabi Usa Llc, Abraxis Pharmaceutical Products, Merck And Co Inc, Gd Searle Llc, Slayback Pharma Llc, Elkins Sinn Div Ah Robins Co Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Adrenergic receptor alpha-1 | PROTEIN FAMILY | AGONIST | CHEMBL2094251 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL136778 | |
PharmGKB | PA164748761 | |
Human Metabolome Database | HMDB0014748 | |
DrugBank | DB00610 | |
PubChem: Thomson Pharma | 15219458 | |
PubChem | 5906 | |
LINCS | LSM-6000 | |
Nikkaji | J4.155F | |
BindingDB | 50239972 | |
EPA CompTox Dashboard | DTXSID8023268 | |
DrugCentral | 1721 | |
Brenda | 247554 | |
ChemicalBook | CB7128262 | |
Guide to Pharmacology | 7229 | |
rxnorm | METARAMINOL BITARTRATE | METARAMINOL |
KEGG Ligand | C07146 | |
ChEBI | 6794 | |
ZINC | ZINC000000001695 |